The global fish protein hydrolysate market size is expected to reach USD 283.4 million by 2028, according to a new study by Polaris Market Research. The report “Fish Protein Hydrolysate Market Share, Size, Trends, Industry Analysis Report, By Form (Liquid, Powder); By Application; By Technology; By Source; By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into the current market dynamics and provides analysis on future market growth.
The growth of the global market is driven by factors such as the increasing applications of fish protein hydrolysate (FPH) in the pharmaceutical, cosmetic, and food and beverages industries in recent years. The increasing focus on developing healthy animal feeds and the increase in aquatic farming are expected to further propel the industry growth during the forecast period.
FPH is known to improve Irritable Bowel Syndrome (IBS) and Crohn’s disease. As they are hypoallergenic, they are used by people suffering from milk allergy, celiac disease, and gluten intolerance. In recent years, natural growth promoters such as fish proteins have been preferred over antibiotic promoters owing to bioaccumulation in poultry animals which is expected to increase the demand for FPH. These products contain omega 3 concentrations. Atlantic salmon contains high levels of health-promoting omega-3.
Omega-3 fatty acids fight depression and anxiety, brain health during pregnancy and early life by reducing the risk of ADHD, autism, and cerebral palsy, improving risk factors for heart disease and reducing symptoms of metabolic syndrome such as hypertension and diabetes by improving insulin resistance. All these factors augment the growth of the global market.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/fish-protein-hydrolysate-market/request-for-sample
Many new developments have been taken place in the global market in recent times. For instance, in May 2021, Garden of Life, owned by Nestle has made its first purchase orders for ProGo, a salmon hydrolysate product developed by Hofseth BioCare (HBC). The launch of new ProGo consumer protein products online in North American is expected to come by 2021.
COVID-19 is expected to have a negative impact on global market growth due to difficulties in transporting FPH during the pandemic period. This has significantly disrupted the supply chain, affecting the manufacturing of various pharmaceutical, food, and beverage products that need FPH as a raw material.
Industry participants such as SOPROPECHE, Alaska Protein Recovery, LLC, Bio-marine Ingredients Ireland Ltd., BrownsFish Genesis, COPALIS SEA SOLUTIONS, Diana Group, Dramm Corporation, Great Pacific BioProducts Ltd., Hofseth BioCare, Janatha Fish Meal & Oil Products, Marutham Bio Ages Innovations (p) Limited, Neptune’s Harvest, New Alliance Dye Chem Pvt. Ltd., SAMPI, Scanbio, Shenzhen Taier, U.S. Ag Florida, Inc., and United Fisheries are some of the key players operating in the global hydrolysate industry.
Polaris Market Research has segmented the fish protein hydrolysate market report on the basis of technology, form, source, application, and region:
Fish Protein Hydrolysate, Technology Outlook (Revenue – USD Million, 2016 – 2028)
- Acid Hydrolysis
- Autolytic Hydrolysis
- Enzymatic Hydrolysis
Fish Protein Hydrolysate, Form Outlook (Revenue – USD Million, 2016 – 2028)
Fish Protein Hydrolysate, Source Outlook (Revenue – USD Million, 2016 – 2028)
Fish Protein Hydrolysate, Application Outlook (Revenue – USD Million, 2016 – 2028)
- Animal Feed & Pet Food
Fish Protein Hydrolysate, Regional Outlook (Revenue – USD Million, 2016 – 2028)
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa